Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
Transcriptomics Dataset
FAIR Metrics
0 evaluations
General Information
| Accession | GSE40050 |
| Title | Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions |
| Description | The androgen receptor (AR) is a ligand-inducible transcription factor that mediates androgen action in target tissues. Upon ligand binding, the AR binds to thousands of genomic loci and activates a cell-type specific gene program. Prostate cancer growth and progression depend on androgen-induced AR signalling. Treatment of advanced prostate cancer through medical or surgical castration leads to initial response and durable remission, but resistance inevitably develops. In castration-resistant prostate cancer (CRPC), AR activity remains critical for tumor growth despite androgen deprivation. While previous studies have focused on ligand-dependent AR signalling, in this study we explore AR function under the androgen-deprived conditions characteristic of CRPC. Our data demonstrate that the AR persistently occupies a distinct set of genomic loci after androgen deprivation in CRPC. These androgen-independent AR occupied regions have constitutively open chromatin structures that lack the canonical androgen response element and are independent of FoxA1, a transcription factor involved in ligand-dependent AR targeting. Many AR binding events occur at proximal promoters, which can act as enhancers to augment transcriptional activities of other promoters through DNA looping. We further show that androgen-independent AR binding directs a distinct gene expression program in CRPC, which is necessary for the growth of CRPC after androgen withdrawal. |
| Landing Page | https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40050 |
| Repository | Gene Expression Omnibus |
Related Datasets
GSE69896
Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor
1
GSE72483
ROR- drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer
1
GSE84432
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells
1
GSE36433
Hes6 expression is controlled by c-Myc and the AR to promote E2F1 activity and poor outcome in castrate-resistant prostate cancer (xenografts)
7
Tools
used to analyze the dataset
Canned Analyses
generated with the dataset
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.
